Bimekizumab Offers Rapid and Durable Psoriasis Treatment

被引:1
|
作者
Slomski, Anita
机构
来源
关键词
D O I
10.1001/jama.2021.5863
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
下载
收藏
页码:1602 / 1602
页数:1
相关论文
共 50 条
  • [41] Bimekizumab for the treatment of psoriatic arthritis
    Tanaka, Yoshiya
    Shaw, Stevan
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2024, 20 (02) : 155 - 168
  • [42] Two cases of generalized pustular psoriasis successfully treated with bimekizumab
    Hagino, Teppei
    Saeki, Hidehisa
    Kanda, Naoko
    JOURNAL OF DERMATOLOGY, 2023, 50 (10): : E357 - E358
  • [43] Bimekizumab for the treatment of moderate to severe psoriasis of the scalp: Post hoc analysis from the BE SURE phase 3 trial
    Reich, Kristian
    Merola, Joseph F.
    Elewski, Boni
    Papp, Kim A.
    Puig, Luis
    Rich, Pheobe
    Cioffi, Christopher
    Cullen, Eva
    Peterson, Luke
    Gottlieb, Alice B.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB70 - AB70
  • [44] Bimekizumab: a dual IL-17A and IL-17F inhibitor for the treatment of psoriasis and psoriatic arthritis
    Ali, Zara
    Matthews, Raymond
    Al-Janabi, Ali
    Warren, Richard B.
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2021, 17 (10) : 1073 - 1081
  • [45] Bimekizumab versus secukinumab for the treatment of nail psoriasis in patients with moderate to severe plaque psoriasis: Results from the BE RADIANT phase 3b trial
    Eyerich, Kilian
    Gottlieb, Alice B.
    Piaserico, Stefano
    Beissert, Stefan
    Gooderham, Melinda
    Kirby, Brian
    Tilt, Nicola
    Madden, Cynthia
    Wiegratz, Susanne
    de Cuyper, Dirk
    Elewski, Boni
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB22 - AB22
  • [46] Bimekizumab versus Secukinumab for the Treatment of Nail Psoriasis in Patients with Moderate to Severe Plaque Psoriasis: Results from the BE RADIANT Phase 3b Trial
    Eyerich, Kilian
    Gottlieb, Alice B.
    Piaserico, Stefano
    Beissert, Stefan
    Gooderham, Melinda
    Kirby, Brian
    Tilt, Nicola
    Madden, Cynthia
    Wiegratz, Susanne
    de Cuyper, Dirk
    Merola, Joseph F.
    Elewski, Boni
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 4467 - 4469
  • [47] Sub-erythrodermic psoriasis successfully treated with bimekizumab: A case report
    Valenti, Mario
    Gargiulo, Luigi
    Ibba, Luciano
    Pavia, Giulia
    Narcisi, Alessandra
    Costanzo, Antonio
    DERMATOLOGIC THERAPY, 2022, 35 (12)
  • [48] Bimekizumab for the Treatment of Plaque Psoriasis with Involvement of Genitalia: A 16-Week Multicenter Real-World Experience - IL PSO (Italian Landscape Psoriasis)
    Orsini, Diego
    Malagoli, Piergiorgio
    Balato, Anna
    Bianchi, Luca
    Brianti, Pina
    Buononato, Dario
    Burlando, Martina
    Caldarola, Giacomo
    Campanati, Anna
    Campione, Elena
    Carrera, Carlo G.
    Carugno, Andrea
    Cusano, Francesco
    Dapavo, Paolo
    Dattola, Annunziata
    De Simone, Clara
    Dini, Valentina
    Esposito, Maria
    Fargnoli, Maria C.
    Gaiani, Francesca M.
    Gargiulo, Luigi
    Gisondi, Paolo
    Giunta, Alessandro
    Ibba, Luciano
    Lasagni, Claudia
    Loconsole, Francesco
    Maione, Vincenzo
    Mortato, Edoardo
    Marzano, Angelo, V
    Maurelli, Martina
    Megna, Matteo
    Mercuri, Santo R.
    Narcisi, Alessandra
    Offidani, Annamaria
    Paolino, Giovanni
    Parodi, Aurora
    Pellacani, Giovanni
    Potestio, Luca
    Quaglino, Pietro
    Richetta, Antonio G.
    Romano, Francesca
    Sena, Paolo
    Venturini, Marina
    Assorgi, Chiara
    Costanzo, Antonio
    DERMATOLOGY PRACTICAL & CONCEPTUAL, 2024, 14 (02):
  • [49] TREATING INTRACTABLE PRURITUS ASSOCIATED WITH ILVEN AND CONCOMITANT PSORIASIS: ACHIEVING SUCCESS WITH BIMEKIZUMAB
    Hanna, Edith
    Noel, Rose
    ACTA DERMATO-VENEREOLOGICA, 2024, 104
  • [50] Bimekizumab in moderate-to-severe plaque psoriasis: population pharmacokinetic and pharmacodynamic relationships
    Vajjah, P.
    Acharya, C.
    Brekkan, A.
    Zamacona, M.
    Nemansky, M.
    Peterson, L.
    MacPherson, M.
    Oliver, R.
    BRITISH JOURNAL OF DERMATOLOGY, 2022, 186 (01) : E47 - E48